Author/Authors :
Eskandarian, Rahimeh Internal Medicine Research Center - Semnan University of Medical Sciences, Semnan , Alizadeh Sani, Zahra Rajaie Cardiovascular Medical and Research Center - Iran University of Medical Sciences , Behjati, Mohaddeseh Rajaie Cardiovascular Medical and Research Center - Iran University of Medical Sciences , Alizadehsani, Roohallah Institute for Intelligent Systems Research and Innovation - Deakin University, Geelong , Shoeibi, Afshin Department of Computer Engineering - Ferdowsi University of Mashhad, Mashhad, Iran , Kakhi, Kourosh Department of Data Science & AI - Monash University , Khosravi, Abbas Institute for Intelligent Systems Research and Innovation - Deakin University, Geelong , Nahavandi, Saeid Institute for Intelligent Systems Research and Innovation - Deakin University, Geelong , Shariful Islam, Sheikh Mohammed Cardiovascular Division - The George Institute for Global Health, Newtown
Abstract :
A 65‑year‑old male was introduced with a history of percutaneous coronary intervention 2 years ago who received Aspirin and Plavix. He was
referred for coronary angiography after receiving thrombolytic therapy for ST‑elevation myocardial infarction in precordial leads. On admission,
he had dyspnea with low oxygen saturation, leukocytosis, lymphopenia, elevated C‑reactive protein, and cardiac troponin levels. Transthoracic
echocardiography demonstrated left ventricular ejection fraction (LVEF) of 25% and pulmonary artery pressure of 45 mmHg. A small thrombus
at the site of the previously deployed stent was noticeable at coronary angiography. The chest computed tomography depicted significant
involvement of the lungs manifested by peripheral ground‑glass opacifications. A positive polymerase chain reaction confirmed coronavirus
infection. He was oxygen dependent for 1 week. Gradually, his respiratory distress improved and his LVEF reached to 30% after discharge.
Keywords :
Coronavirus , COVID‑19 , ST‑elevation myocardial infarction , stent thrombosis
